Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 2 subfamily F member 2, pseudogene (CYP2F2P)
- Target
- CYP2F2P
- Molecular classification
- Pseudogene, Related to the Cytochrome P450 family (but not an active enzyme)
01
Overview
Cytochrome P450 family 2 subfamily F member 2, pseudogene (CYP2F2P) is a non-protein coding pseudogene belonging to the cytochrome P450 gene family. While the cytochrome P450 superfamily includes many active enzymes involved in drug metabolism, toxin breakdown, and biosynthetic processes, CYP2F2P itself does not encode a functional protein, lacks enzymatic activity, and is not considered a therapeutic target[1][5][9]. Its sequence is related to other cytochrome P450 genes, such as CYP2F2 (mouse) and CYP2F1 (human), which are active enzymes, but CYP2F2P contains mutations or truncations rendering it inactive. No therapeutic roles, drug interactions, or biomarker utility are established for CYP2F2P.
- Other names
- Cytochrome P450, Family 2, Subfamily F, Polypeptide 2, PseudogeneCYP2F1PCytochrome P450, Subfamily IIF, Polypeptide 1 Pseudogene
02
Mechanism of action
None; not a functional gene or protein target
03
Biological functions
None established; lacks protein product and known biological function as a pseudogene
04
Disease associations
None established; not associated with disease as an active participant
05
Safety considerations
None directly; not a therapeutic target, thus not relevant for safety assessments
06
Interacting drugs
None; does not encode a protein and thus has no known drug interactions
07
Biomarkers
None; not used in patient selection or efficacy monitoring
Beyond the preview
Go deeper on Cytochrome P450 family 2 subfamily F member 2, pseudogene (CYP2F2P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytochrome P450 family 2 subfamily F member 2, pseudogene (CYP2F2P).